NCT04004338View on ClinicalTrials.gov

Carfilzomib in Combination for the Treatment of RR MM

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 14, 2019

Primary Completion Date

April 14, 2021

Study Completion Date

April 14, 2021

Conditions
Multiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma
Interventions
DRUG

Kyprolis

Patients receiving kyprolis (carfilzomib)

Trial Locations (1)

Unknown

RECRUITING

19 Mayıs University Faculty of Medicine, Samsun

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Black Sea Hematology Association

OTHER

NCT04004338 - Carfilzomib in Combination for the Treatment of RR MM | Biotech Hunter | Biotech Hunter